The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan
Our results offer insights into the real-world application of CGP testing for patients with mCRPC at a cooperative hospital for cancer genomic medicine in Japan. Thus, urologists require a comprehensive understanding of the current status of CGP testing to enhance mCRPC management.
Authors
- Yoichiro Yamamoto (ORCID: https://orcid.org/0000-0003-0799-4338)
- Yuka Toyama
- Hikaru Mikami (ORCID: https://orcid.org/0009-0001-5555-5789)
- Kotaro Obayashi (ORCID: https://orcid.org/0009-0001-0427-0644)
- Yukihiro Kondo (ORCID: https://orcid.org/0000-0003-4141-9230)
- Go Kimura (ORCID: https://orcid.org/0000-0003-0088-9324)
- Takuma Iwai (ORCID: https://orcid.org/0000-0002-4706-1228)
- Yuki Endo (ORCID: https://orcid.org/0009-0002-0787-9321)
- Sayuri Hiraoka
- Tomoko Sahara
- Yamada Takeshi
- Jun Akatsuka (ORCID: https://orcid.org/0000-0003-3115-6043)
- Hiroya Hasegawa
- Hayato Takeda (ORCID: https://orcid.org/0000-0002-4556-6601)
- Mami Takadate
Institutions
- Tohoku University (JP)
- RIKEN Center for Advanced Intelligence Project (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Journal of Nippon Medical School
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1272/jnms.jnms.2024_91-512
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Moonshot Research and Development Program